Elomaa AI - Search Results

1

S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome.

Huuhtanen RL, Blomqvist CP, Wiklund TA, Virolainen MJ, Elomaa AI, Pan Y, Tribukait B. Huuhtanen RL, et al. Among authors: elomaa ai. Cancer. 1996 May 1;77(9):1815-22. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1815::AID-CNCR9>3.0.CO;2-A. Cancer. 1996. PMID: 8646679

2

Comparative genomic hybridization of postirradiation sarcomas.

Tarkkanen M, Wiklund TA, Virolainen MJ, Larramendy ML, Mandahl N, Mertens F, Blomqvist CP, Tukiainen EJ, Miettinen MM, Elomaa AI, Knuutila YS. Tarkkanen M, et al. Among authors: elomaa ai. Cancer. 2001 Oct 1;92(7):1992-8. doi: 10.1002/1097-0142(20011001)92:7<1992::aid-cncr1719>3.0.co;2-2. Cancer. 2001. PMID: 11745275

3

Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries.

Kallonen T, Gröndahl-Yli-Hannuksela K, Elomaa A, Lutyńska A, Fry NK, Mertsola J, He Q. Kallonen T, et al. Infect Genet Evol. 2011 Dec;11(8):2034-42. doi: 10.1016/j.meegid.2011.09.012. Epub 2011 Sep 21. Infect Genet Evol. 2011. PMID: 21964035

4

Homogeneous time-resolved fluorescence quenching assay (TruPoint) for nucleic acid detection.

Ylikoski A, Elomaa A, Ollikka P, Hakala H, Mukkala VM, Hovinen J, Hemmilä I. Ylikoski A, et al. Clin Chem. 2004 Oct;50(10):1943-7. doi: 10.1373/clinchem.2004.036616. Clin Chem. 2004. PMID: 15484334 No abstract available.

5

Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years.

Elomaa A, Advani A, Donnelly D, Antila M, Mertsola J, Hallander H, He Q. Elomaa A, et al. J Clin Microbiol. 2005 Aug;43(8):3681-7. doi: 10.1128/JCM.43.8.3681-3687.2005. J Clin Microbiol. 2005. PMID: 16081896 Free PMC article.

6

Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories.

Elomaa A, Advani A, Donnelly D, Antila M, Mertsola J, He Q, Hallander H. Elomaa A, et al. Vaccine. 2007 Jan 15;25(5):918-26. doi: 10.1016/j.vaccine.2006.09.012. Epub 2006 Sep 20. Vaccine. 2007. PMID: 17030495

7

Pertussis before and after the introduction of acellular pertussis vaccines in Finland.

Elomaa A, He Q, Minh NN, Mertsola J. Elomaa A, et al. Vaccine. 2009 Sep 4;27(40):5443-9. doi: 10.1016/j.vaccine.2009.07.010. Epub 2009 Jul 21. Vaccine. 2009. PMID: 19628060

8

Bordetella pertussis, Finland and France.

Caro V, Elomaa A, Brun D, Mertsola J, He Q, Guiso N. Caro V, et al. Emerg Infect Dis. 2006 Jun;12(6):987-9. doi: 10.3201/eid1206.051283. Emerg Infect Dis. 2006. PMID: 16707058 Free PMC article.

9

Bordetella pertussis vaccine strains and circulating isolates in Serbia.

Dakic G, Kallonen T, Elomaa A, Pljesa T, Vignjevic-Krastavcevic M, He Q. Dakic G, et al. Vaccine. 2010 Feb 3;28(5):1188-92. doi: 10.1016/j.vaccine.2009.11.036. Epub 2009 Nov 27. Vaccine. 2010. PMID: 19945417

10

Caspase multiplexing: simultaneous homogeneous time-resolved quenching assay (TruPoint) for caspases 1, 3, and 6.

Karvinen J, Elomaa A, Mäkinen ML, Hakala H, Mukkala VM, Peuralahti J, Hurskainen P, Hovinen J, Hemmilä I. Karvinen J, et al. Anal Biochem. 2004 Feb 15;325(2):317-25. doi: 10.1016/j.ab.2003.10.044. Anal Biochem. 2004. PMID: 14751267

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page